Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion
Why Five Prime Therapeutics Stock Is Skyrocketing Today
Is It Time to Buy the Dow Jones' 3 Worst-Performing February Stocks?
Why Amgen's Q4 Earnings Beat Didn't Impress Investors
Amgen Inc (AMGN) Q4 2020 Earnings Call Transcript
3 Top Biotech Picks for January
2 Top Stocks for Retirees
Forget Apple: Here's a Better Dividend Growth Stock
3 Dividend Stocks That Have Doubled Their Payouts in 5 Years
About · FAQs · StocksCafe © 2024 · Privacy · Terms